MathiasLichterfeldMD
Infectious Disease • Boston, MAInfectious Disease Division Massachusetts General Hospital
Dr. Lichterfeld is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
Boston, MA 11794Phone+1 617-724-6620Fax+1 617-726-5411
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2008 - 2010- Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2008
- Massachusetts General HospitalInternship, Internal Medicine, 2006 - 2007
University of Bonn Faculty of MedicineClass of 2000
Certifications & Licensure
MA State Medical License 2008 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
- National Board of Physicians and Surgeons Infectious Disease
- National Board of Physicians and Surgeons Internal Medicine
Clinical Trials
- Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) Start of enrollment: 2005 Jun 01
- Dual bNAb Treatment in Children Start of enrollment: 2019 Jun 17
Publications & Presentations
PubMed
- Differential immunophenotype and proviral composition in young adults with perinatally acquired HIV: Are special cure strategies needed?Lucia Baquero, Sofía Stöver, Marie Armani Tourret, Ailén Perbelis, Alejandra Urioste
AIDS. 2024-11-26 - John Phair.Michael Saag, Roel Coutinho, Sarah Rowland-Jones, Mathias Lichterfeld, Jay Levy
AIDS. 2024-11-15 - Profound reduction of HIV-1 reservoir cells over three decades of antiretroviral therapy started in early infancy.Liliana C Vela, Leah Carrere, Chloe Naasz, Sruthi Kalavacherla, Toong Seng Tan
JCI Insight. 2024-11-14
Press Mentions
Single-Cell Studies Offer New View of How HIV Infections Persist—and Might Be CuredAugust 3rd, 2022- Mapping Where HIV Hides Its Genes Suggests Cure StrategyJanuary 12th, 2022
- Researchers Identify New HIV Patient Who Appears to Have Been ‘Cured’ Without TreatmentNovember 19th, 2021
- Join now to see all
Grant Support
- Limiting HIV-1 persistence by targeting stem cell properties of cellular immune memoryNational Institute of Allergy and Infectious Diseases (NIAID)2013–Present
- Innate Resistance Of CD4 T Cells To HIV-1 Infection In Elite ControllersNational Institute Of Allergy And Infectious Diseases2011–2012
Professional Memberships
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
